ATE169629T1 - Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen - Google Patents

Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen

Info

Publication number
ATE169629T1
ATE169629T1 AT95928857T AT95928857T ATE169629T1 AT E169629 T1 ATE169629 T1 AT E169629T1 AT 95928857 T AT95928857 T AT 95928857T AT 95928857 T AT95928857 T AT 95928857T AT E169629 T1 ATE169629 T1 AT E169629T1
Authority
AT
Austria
Prior art keywords
treatment
nervous system
alkylamines
acyl
central nervous
Prior art date
Application number
AT95928857T
Other languages
English (en)
Inventor
Valle Francesco Della
Alberta Leon
Gabriele Marcolongo
Valle Federica Della
Original Assignee
Lifegroup Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifegroup Spa filed Critical Lifegroup Spa
Application granted granted Critical
Publication of ATE169629T1 publication Critical patent/ATE169629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT95928857T 1994-03-21 1995-03-20 Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen ATE169629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940524A IT1271624B (it) 1994-03-21 1994-03-21 Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'

Publications (1)

Publication Number Publication Date
ATE169629T1 true ATE169629T1 (de) 1998-08-15

Family

ID=11368282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928857T ATE169629T1 (de) 1994-03-21 1995-03-20 Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen

Country Status (9)

Country Link
EP (1) EP0751947B1 (de)
JP (1) JP4063864B2 (de)
AT (1) ATE169629T1 (de)
AU (1) AU2110095A (de)
DE (1) DE69504048T2 (de)
DK (1) DK0751947T3 (de)
ES (1) ES2124012T3 (de)
IT (1) IT1271624B (de)
WO (1) WO1995025736A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070966B2 (ja) * 2001-06-28 2008-04-02 株式会社カネボウ化粧品 新規ガラクトシルセラミド類縁体及び用途
DE602006013787D1 (de) * 2006-03-28 2010-06-02 Epitech Group Srl Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden
KR101116868B1 (ko) * 2008-10-20 2012-02-29 성균관대학교산학협력단 안질환의 예방 또는 치료용 조성물
EP2925769A4 (de) * 2012-11-28 2016-07-06 Victoria Link Ltd Dendritische saccharidclusterverbindungen als bace-1-inhibitoren
US9828341B2 (en) 2012-11-28 2017-11-28 Victoria Link Limited Dendritic core compounds
CN105418698B (zh) * 2015-12-21 2018-04-27 上海市第七人民医院 一种酰胺乙氧基-β-D-葡萄糖苷类化合物及其制备方法和应用
US11186603B2 (en) 2017-03-23 2021-11-30 Victoria Link Limited Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses
US12611419B2 (en) 2017-12-21 2026-04-28 Innomedica Holding Ag Liposomal composition for use in a method of treating Parkinson's disease
CN115466178B (zh) * 2021-06-11 2024-06-11 青岛海合生物科技有限公司 一种神经酸衍生物及其制备方法和应用
FR3147951A1 (fr) * 2023-04-19 2024-10-25 Paris Sciences Et Lettres Particules de monosaccharides modifies par une chaine hydrophobe et de cyclodextrine.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico

Also Published As

Publication number Publication date
DE69504048T2 (de) 1999-04-22
DE69504048D1 (de) 1998-09-17
EP0751947B1 (de) 1998-08-12
DK0751947T3 (da) 1999-05-10
IT1271624B (it) 1997-06-04
ITMI940524A1 (it) 1995-09-21
WO1995025736A1 (en) 1995-09-28
JP4063864B2 (ja) 2008-03-19
ES2124012T3 (es) 1999-01-16
EP0751947A1 (de) 1997-01-08
JPH09510469A (ja) 1997-10-21
AU2110095A (en) 1995-10-09
ITMI940524A0 (it) 1994-03-21

Similar Documents

Publication Publication Date Title
ATE222763T1 (de) Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien
MY115977A (en) Synthetic excitatory amino acids
ITMI930699A1 (it) Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
NL300406I1 (nl) Gesubstitueerde dihydrodibenzo (d,f)azepinen, werkwijze ter bereiding ervan, hun toepassing bij het behandelen van enkele verstoringen van het centraal zenuwsysteem, en farmaceutische samenstellingen die ze bevatten
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
CA2258895A1 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
FI911986A0 (fi) Farmaceutiska foereningar.
HUP0003298A3 (en) Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
BR9916461A (pt) ácidos carboxìlicos e isósteres de ácido carboxìlico de compostos n-heterocìclicos
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
EP1019057A4 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
PL316533A1 (en) Progesterone antagonists used for producing therapeutic agents useful in treating dysfunctional metrorrhagiae
FI963511A7 (fi) Pakko-oireisten häiriöiden hoito 5-HT2-antagonisteilla
DE69504048D1 (de) Glukosid-derivate von n-acyl-alkylaminen mit neuroprotektiver,neurotrophischer und entzündungshemmender wirkung für die behandlung von zentralnervensystemerkrankungen
NO975234D0 (no) Fremgangsmåte for behandling av maniske og bipolare forstyrrelser
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
BG104801A (en) Indole-2,3-dione-3-oxime derivatives for therapeutical use
ES2115055T3 (es) 1-fenil-2-(2-piridinil)etilamina enantiomera para el tratamiento de trastornos neurodegenerativos.
TR200003356T2 (tr) Kabergolin ve pramipeksol: yeni kullanım biçimleri ve birlikte kullanılmaları.
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee